期刊文献+

酶联免疫法测定去氨加压素血药浓度及其药动学 被引量:2

Study on the pharmacokinetics and ELISA method used for determining the blood concentration of desmopressin
原文传递
导出
摘要 目的:建立用酶联免疫(ELISA)法测定去氨加压素血药浓度的快速、简便方法,并研究其药动学。方法:用人去氨加压素(dDAVP)ELISA试剂盒对8例受试者给药后各时间段的血样进行血管加压素含量测定,用SPSS 18.0对检测平均值作药时曲线图并计算药动学相关参数。结果:ELISA法测定去氨加压素标准曲线回归方程为:Y=92.364 X+9.655 5,R2=0.998 1,平均回收率为100.96%;t1/2=(81.1±10.9)min;Cmax=(175.1±8.8)pg·mL-1;AUC0→200=(18 415±964)pg·h·mL-1;ClT=(52.8±2.6)mL·min-1。结论:ELISA法用于测定去氨加压素血药浓度及药动学研究的方法快速方便,结果稳定可靠。 To develop a simple and rapid method for determining the concentration of desmopressin and study its pharmacokinetices. METHODS Blood samples of 8 patients collected at different time after administration were determined using ELISA kit. The AUC and pharmacokinetics parameters were calcultated by SPSS 18.0 software. RESULTS The calcula tion curve was Y= 92. 364X+ 9. 655 5,R2 = 0. 998 1. Recovery rate was 100. 96%. Half life time was (81.1± 10. 9)rain and Cm.x was (175.1± 8. 8)pg.mL 1. AUC2.. was (18 415± 964)pg-h-mL i. CIT was (52. 8± 2. 6)mL.min-1. CONCLUSION The developed method to study the concentration and pharmaeokinetics of desmopressin using ELISA was fast and reliable.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2013年第18期1503-1505,共3页 Chinese Journal of Hospital Pharmacy
基金 江苏省无锡市医院管理中心科研基金项目(编号:YGM1008)
关键词 酶联免疫法(ELISA) 去氨加压素 含量测定 药动学 ELISA desmopressin concentration determination pharmacokinetics
  • 相关文献

参考文献3

二级参考文献13

  • 1高宇飞,赵丛海,翟振宏.鞍区肿瘤术后水钠失衡的诊断及临床分析[J].中国实验诊断学,2005,9(5):672-674. 被引量:6
  • 2高宇飞,翟振宏,仲丛江,阎芳.重型颅脑损伤并发低钠血症抗利尿激素和心钠素的变化及意义[J].中国实验诊断学,2006,10(5):505-508. 被引量:6
  • 3岳希全,石宏,李迎.ELISA法检测HBsAg影响结果的重要因素的分析[J].中国实验诊断学,2007,11(2):213-215. 被引量:26
  • 4Wong MF, Chin NM, Lew TW . Diabetes insipidus in neurosurgieal patients[J]. Ann Aead Med Singapore, 1998,27 (3): 340-343.
  • 5Saeki N, Tokunaga H, Wagai N, et al . MRI of eetopic posterior pituitary bright spot with large adenomas :appearances and relationship to transient postoperative diabetes insipidus [J].Neuroradiology, 2003, 45 (10) :713-716.
  • 6Maghnie M. Diabetes insipidus[J]. Horm Res, 2003,59 (Suppl 1): 42-54.
  • 7Verbalis JG. Management of disorders of water metabolism in patients with pituitary tumors[J].Pituitary, 2002, 5 (2):119-132.
  • 8Fukino K, Yamada S, Ohta T, et al. Serial MR intensity changes of the posterior pituitary in patients with diabetes insipidus after transsphenoidal surgery for pituitary adenomas: report of two cases[J].Pituitary, 2003, 6 (4):215-219.
  • 9Fukuda I, Hizuka N, Takano K. Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment[J]. Endoer J,2003, 50 (4):437-443.
  • 10徐锋,李筱莉,陈燕.不同孵育条件对HBsAg定性分析的影响[J].国际检验医学杂志,2008,29(10):933-933. 被引量:2

共引文献364

同被引文献22

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部